Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Adagio Therapeutics IncCommon Stock stock

Learn how to easily invest in Adagio Therapeutics IncCommon Stock stock.

Adagio Therapeutics wrapped its initial public offering, raising $309.4 million after selling 18.2 million shares at $17 each, right in the middle of its $16 to $18 range.

Shares of ADGI will begin trading later this afternoon, but shares are available for limit orders on Robinhood and other platforms.

How to buy shares in Adagio Therapeutics IncCommon Stock

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ADGI – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Adagio Therapeutics IncCommon Stock stock price (NASDAQ: ADGI)

Use our graph to track the performance of ADGI stocks over time.

Adagio Therapeutics IncCommon Stock shares at a glance

Information last updated 2022-01-13.
Latest market close$5.70
52-week range$5.57 - $59.50
50-day moving average $20.06
200-day moving average $28.49
Wall St. target price$8.33
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-14.74

Buy Adagio Therapeutics IncCommon Stock shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
SoFi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
Stocks, Options, ETFs
$0
$0 per year
Get a free stock valued up to $3500
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
$125 - $625
Open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Adagio Therapeutics IncCommon Stock stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Adagio Therapeutics IncCommon Stock price performance over time

Historical closes compared with the close of $5.7 from 2022-01-14

1 week (2022-01-10) -6.71%
1 month (2021-12-16) -59.80%
3 months (2021-10-18) -83.05%
6 months (2021-07-14) N/A
1 year (2021-01-14) N/A
2 years (2020-01-14) N/A
3 years (2019-01-14) N/A
5 years (2017-01-14) N/A

Adagio Therapeutics IncCommon Stock financials

Gross profit TTM $0
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin 0%
Book value $5.69
Market capitalisation $648.6 million

TTM: trailing 12 months

Adagio Therapeutics IncCommon Stock share dividends

We're not expecting Adagio Therapeutics IncCommon Stock to pay a dividend over the next 12 months.

You may also wish to consider:

Adagio Therapeutics IncCommon Stock overview

Adagio Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. Its lead product candidate is the ADG20, a neutralizing antibody that is in Phase II/III clinical trials for the treatment and prevention of coronavirus disease. The company has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies. Adagio Therapeutics, Inc. was incorporated in 2020 and is based in Waltham, Massachusetts. .

Frequently asked questions

What percentage of Adagio Therapeutics IncCommon Stock is owned by insiders or institutions?
Currently 53.497% of Adagio Therapeutics IncCommon Stock shares are held by insiders and 65.368% by institutions.
When does the fiscal year end for Adagio Therapeutics IncCommon Stock?
Adagio Therapeutics IncCommon Stock's fiscal year ends in December.
Where is Adagio Therapeutics IncCommon Stock based?
Adagio Therapeutics IncCommon Stock's address is: 303 Wyman Street, Waltham, MA, United States, 02451
What is Adagio Therapeutics IncCommon Stock's ISIN number?
Adagio Therapeutics IncCommon Stock's international securities identification number is: US00534A1025
What is Adagio Therapeutics IncCommon Stock's CUSIP number?
Adagio Therapeutics IncCommon Stock's Committee on Uniform Securities Identification Procedures number is: 019483106

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site